Patents by Inventor Soon-Young Jeong

Soon-Young Jeong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Indirubin-3?-oxime derivatives as potent cyclin dependent kinase inhibitors
    Patent number: 8859783
    Abstract: The present invention relates to an indirubin-3?-oxime derivative as potent cyclin dependent kinase inhibitor with anti-cancer activity. More particularly, this invention relates to an indirubin-3?-oxime derivative as potent cyclin dependent kinase inhibitor having excellent anti-cancer activity against human lung cancer cell, human fibro sarcoma cell, human colon cancer cell, human leukemia cell, human stomach cancer cell, human nasopharyngeal cancer cell and/or human breast cancer cell.
    Type: Grant
    Filed: January 28, 2011
    Date of Patent: October 14, 2014
    Assignee: Anygen Co., Ltd.
    Inventors: Yong-Chul Kim, Jae-Il Kim, Soo-Ho Ban, Soon-Young Jeong, Soo-Jeong Choi, Jung-Eun Lee
  • INDIRUBIN-3'-OXIME DERIVATIVES AS POTENT CYCLIN DEPENDENT KINASE INHIBITORS
    Publication number: 20120295948
    Abstract: The present invention relates to an indirubin-3?-oxime derivative as potent cyclin dependent kinase inhibitor with anti-cancer activity. More particularly, this invention relates to an indirubin-3?-oxime derivative as potent cyclin dependent kinase inhibitor having excellent anti-cancer activity against human lung cancer cell, human fibro sarcoma cell, human colon cancer cell, human leukemia cell, human stomach cancer cell, human nasopharyngeal cancer cell and/or human breast cancer cell.
    Type: Application
    Filed: January 28, 2011
    Publication date: November 22, 2012
    Applicant: ANYGEN CO., LTD.
    Inventors: Yong-Chul Kim, Jae-II Kim, Soo-Ho Ban, Soon-Young Jeong, Soo-Jeong Choi, Jung-Eun Lee